Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke.
Author(s) -
Rüdiger von Kummer,
Werner Hacke
Publication year - 1992
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/01.str.23.5.646
Subject(s) - medicine , heparin , middle cerebral artery , stroke (engine) , acute stroke , thrombolysis , tissue plasminogen activator , plasminogen activator , anesthesia , cardiology , ischemia , myocardial infarction , mechanical engineering , engineering
There is little reported of the safety and efficacy of high-dose intravenous recombinant tissue plasminogen activator (alteplase) in combination with heparin anticoagulation in patients presenting with acute ischemic stroke.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom